Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online March 9, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0439v1
24/6/1564    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yeoh, J. S.G.
Right arrow Articles by de Haan, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yeoh, J. S.G.
Right arrow Articles by de Haan, G.
Submitted on September 8, 2005
Accepted on March 5, 2006

Tissue-Specific Stem Cells

Fibroblast growth factor-1 and 2 preserve long-term repopulating ability of hematopoietic stem cells in serum-free cultures

Joyce S.G. Yeoh 1, Ronald van Os 1, Ellen Weersing 1, Albertina Ausema 1, Bert Dontje 1, Edo Vellenga 2, Gerald de Haan 1*

1 Department of Cell Biology, Section Stem Cell Biology, University Medical Centre Groningen, Groningen, The Netherlands
2 Department of Hematology, University Medical Centre Groningen, Groningen, The Netherlands

* To whom correspondence should be addressed. E-mail: g.de.haan{at}med.umcg.nl.


   Abstract

In this study we demonstrate that extended culture of unfractionated mouse bone marrow (BM) cells, in serum-free medium, supplemented only with Fibroblast Growth Factor (FGF)-1, FGF-2 or FGF-1+2 preserves long-term repopulating (LTR) hematopoietic stem cells (HSCs). Using competitive repopulation assays, high levels of stem cell activity were detectable at 1, 3 and 5 weeks after initiation of culture. FGFs as single growth factors failed to support cultures of highly purified Lin-Sca-1+c-Kit+ (LSK) cells. However, co-cultures of purified CD45.1 LSK cells with whole BM CD45.2 cells provided high levels of CD45.1 chimerism after transplant, showing that HSC activity originated from LSK cells. Subsequently, we tested reconstituting potential of cells cultured in FGF-1+2 with the addition of early acting stimulatory molecules, stem cell factor (SCF) + interleukin (IL)-11 + Flt3 ligand (Flt3L). The addition of these growth factors resulted in a strong mitogenic response, inducing rapid differentiation thereby completely overriding FGF-dependent stem cell conservation. Importantly, although HSC activity is typically rapidly lost after short term culture in vitro, our current protocol allows us to sustain stem cell repopulation potential for periods up to 5 weeks.




This article has been cited by other articles:


Home page
Stem CellsHome page
S. Noda, K. Horiguchi, H. Ichikawa, and H. Miyoshi
Repopulating Activity of Ex Vivo-Expanded Murine Hematopoietic Stem Cells Resides in the CD48-c-Kit+Sca-1+Lineage Marker- Cell Population
Stem Cells, March 1, 2008; 26(3): 646 - 655.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. Blank, G. Karlsson, and S. Karlsson
Signaling pathways governing stem-cell fate
Blood, January 15, 2008; 111(2): 492 - 503.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. A. Panepucci, R. T. Calado, V. Rocha, R. Proto-Siqueira, W. A. Silva Jr., and M. A. Zago
Higher Expression of Transcription Targets and Components of the Nuclear Factor-{kappa}B Pathway Is a Distinctive Feature of Umbilical Cord Blood CD34+ Precursors
Stem Cells, January 1, 2007; 25(1): 189 - 196.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Rizo, E. Vellenga, G. de Haan, and J. J. Schuringa
Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche?
Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R210 - R219.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 2006 by AlphaMed Press.